Using mass measurements in tracer studies--a systematic approach to efficient modeling.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Metabolism: Clinical and Experimental

• Publication date

  2008-08-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.metabol.2008.03.011PMID 18640385PMCID PMC2601710
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rapid turnover of apolipoprotein C-III-containing triglyceride-rich lipoproteins contributing to the formation of LDL subfractionss⃞ Published, JLR Papers in Press, February 21, 2007.

  2007cited by this paper
• Effect of Ezetimibe on the In Vivo Kinetics of ApoB-48 and ApoB-100 in Men With Primary Hypercholesterolemia

  2006cited by this paper
• Thematic review series: Patient-Oriented Research. Design and analysis of lipoprotein tracer kinetics studies in humans Published, JLR Papers in Press, May 25, 2006.

  2006cited by this paper
• Microsomal triglyceride transfer protein -493T variant reduces IDL plus LDL apoB production and the plasma concentration of large LDL particles.

  2006cited by this paper
• Effects of the PPARgamma agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus.

  2005cited by this paper
• A new combined multicompartmental model for apolipoprotein B-100 and triglyceride metabolism in VLDL subfractions Published, JLR Papers in Press, October 16, 2004. DOI 10.1194/jlr.M400108-JLR200

  2005cited by this paper
• Effects of the PPARγ agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus

  2005influential reference
• Lipoprotein transport in the metabolic syndrome: methodological aspects of stable isotope kinetic studies.

  2004influential reference
• Interrelationships Between Human Apolipoprotein A-I and Apolipoproteins B-48 and B-100 Kinetics Using Stable Isotopes

  2004cited by this paper
• Kinetic studies of lipoprotein metabolism in the metabolic syndrome including effects of nutritional interventions

  2003cited by this paper
• Apolipoprotein B-100 kinetics in visceral obesity: associations with plasma apolipoprotein C-III concentration.

  2002cited by this paper
• The coffee diterpene cafestol increases plasma triacylglycerol by increasing the production rate of large VLDL apolipoprotein B in healthy normolipidemic subjects.

  2001cited by this paper
• Differential Metabolism of Human VLDL According to Content of ApoE and ApoC-III

  2001cited by this paper
• Effect of heparin-stimulated plasma lipolytic activity on VLDL APO B subclass metabolism in normal subjects.

  1999cited by this paper
• Human apolipoprotein (Apo) B-48 and ApoB-100 kinetics with stable isotopes.

  1999cited by this paper
• Compartmental models: theory and practice using the SAAM II software system.

  1998cited by this paper
• SAAM II: Simulation, Analysis, and Modeling Software for tracer and pharmacokinetic studies.

  1998influential reference
• Using what is accessible to measure that which is not: necessity of model of system.

  1998cited by this paper
• Development of compartmental models in stable-isotope experiments: application to lipid metabolism.

  1998influential reference
• Decreased production and increased catabolism of apolipoprotein B-100 in apolipoprotein B-67/B-100 heterozygotes.

  1997cited by this paper
• Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM

  1997cited by this paper
• Metabolic basis of hypotriglyceridemic effects of insulin in normal men.

  1997cited by this paper
• Design and analysis of lipid tracer kinetic studies

  1996cited by this paper
• Sensitive methods to study human apolipoprotein B metabolism using stable isotope-labeled amino acids.

  1996cited by this paper
• Sensitive Mass Spectrometry Techniques for Measuring Metabolism of Human Apolipoprotein B In Vivo

  1994cited by this paper
• Estimating the fractional synthetic rate of plasma apolipoproteins and lipids from stable isotope data.

  1993cited by this paper
• Effects of low dose oral contraceptives on very low density and low density lipoprotein metabolism.

  1993cited by this paper
• Measurement of human apolipoprotein B-48 and B-100 kinetics in triglyceride-rich lipoproteins using [5,5,5-2H3]leucine.

  1992cited by this paper
• Lovastatin therapy reduces low density lipoprotein apoB levels in subjects with combined hyperlipidemia by reducing the production of apoB-containing lipoproteins: implications for the pathophysiology of apoB production.

  1990cited by this paper
• Measurement of very low density and low density lipoprotein apolipoprotein (Apo) B-100 and high density lipoprotein Apo A-I production in human subjects using deuterated leucine. Effect of fasting and feeding.

  1990cited by this paper
• Pool size and mass flux bounds and quasiidentifiability relations for catenary models

  1988cited by this paper
• Compartmental analysis in biology and medicine

  1985cited by this paper
• Some extensions to the exhaustive-modeling approach to structural identifiability

  1985cited by this paper
• Structural equivalence and exhaustive compartmental modeling

  1984cited by this paper
• A Proof of the Occupancy Principle and the Mean-Transit-Time Theorem for Compartmental Models.

  1984cited by this paper
• An Application of Berman's Work on Pool-Model Invariants in Analyzing Indistinguishable Models for Whole-Body Cholesterol Metabolism.

  1984cited by this paper
• Mean residence time—theoretical development, experimental determination, and practical use in tracer analysis☆

  1984cited by this paper
• Complete parameter bounds and quasiidentifiability conditions for a class of unidentifiable linear systems

  1983cited by this paper
• Lipoprotein Kinetics and Modeling

  1982cited by this paper
• 1 – Kinetic Analysis and Modeling: Theory and Applications to Lipoproteins

  1982cited by this paper
• Unidentifiable compartmental models: what to do?

  1981cited by this paper
• Prediction of the parameters of whole body cholesterol metabolism in humans.

  1980cited by this paper
• Apolipoprotein B metabolism in normal, type IV and type V hyperlipoproteinemic subjects.

  1980cited by this paper
• Matrix proof of flow, volume and mean transit time theorems for regional and compartmental systems.

  1975cited by this paper
• A note on open linear systems

  1974cited by this paper
• Effects of thyroid disease on glucose oxidative metabolism in man. A compartmental model analysis.

  1971cited by this paper
• Interpretation of tracer data.

  1969cited by this paper
• Nomenclature for tracer kinetics.

  1968cited by this paper
• Process Analysis and Simulation. Deterministic Systems

  1968cited by this paper
• The washout curve in tracer kinetics

  1968cited by this paper
• Multicompartmental analysis of calcium kinetics in normal adult males.

  1967cited by this paper
• Drug and tracer kinetics

  1966cited by this paper
• THEOREMS ON LINEAR SYSTEMS *

  1963cited by this paper
• Invariants in Experimental Data on Linear Kinetics and the Formulation of Models

  1956cited by this paper

• Relationship of apolipoprotein(a) isoform size with clearance and production of lipoprotein(a) in a diverse cohort

  2023cites this paper
• Effects of Administration of Recombinant Human Lecithin-Cholesterol Acyltransferase on Lipoprotein Metabolism in Humans

  2023cites this paper
• TM6SF2 Determines Both the Degree of Lipidation and the Number of VLDL Particles Secreted by the Liver

  2023cites this paper
• Unravelling Lipoprotein Metabolism with Stable Isotopes: Tracing the Flow.

  2021cites this paper
• Effects of APOC3 Heterozygous Deficiency on Plasma Lipid and Lipoprotein Metabolism

  2019cites this paper
• Complex effects of inhibiting hepatic apolipoprotein B100 synthesis in humans

  2016cites this paper
• Gaussian Process Modeling of Protein Turnover.

  2016cites this paper
• A State Space Transformation Can Yield Identifiable Models for Tracer Kinetic Studies with Enrichment Data

  2010cites this paper
• Arteriosclerosis, Thrombosis, and Vascular Biology

  year unknowncites this paper